Status:
COMPLETED
A Feasibility Study to Investigate the Dynamic Brain Imaging in Patients Following SCS- DRG
Lead Sponsor:
Barts & The London NHS Trust
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-80 years
Brief Summary
Targeted SCS is a standard and safe interventional pain procedure that is offered to patients with intractable neuropathic pain for their symptomatic relief. The known and reported complications inclu...
Detailed Description
Targeted Spinal Cord Stimulation (SCS) using dorsal root ganglion (DRG) stimulation is an effective therapy for a number of different chronic painful conditions of neuropathic origin. British Pain Soc...
Eligibility Criteria
Inclusion
- Male and female patients between the age of 18-80 years who has intractable neuropathic pain.
- Minimum baseline pain rating of 50mm on a 100mm NRS in the back and/or leg
- Chronic pain of at least 6 months
- Subject satisfies standard criteria in the study centre for SCS implantation and the NICE 159 criteria for management of intractable neuropathic pain.
- Patients who have given their written informed consent.
- Patient is able and willing to comply with study procedures and follow up schedule.
Exclusion
- Female patients of childbearing age who is or plans on becoming pregnant during the course of the study
- Patients who have undergone radiofrequency or injection therapy at or on a target neural structure (DRG) during the past 90 days
- Patient deemed unsuitable to have targeted SCS as assessed by the MDT.
- Patients known to have a condition that in the investigator's judgement precludes participation in the study.
- Patients who have received an investigational drug or have used an investigational device in the 30 days proceeding to study entry
- Patients who are needle phobic or claustrophobic.
- Known allergic reaction to radio-contrast.
- Patients who are at high risk of a radiation hazard (previous radiation induced injury or cancer or previously received high radiation doses).
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04508127
Start Date
March 1 2016
End Date
March 1 2018
Last Update
August 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.